value focused midd: influenza model-informed drug development program
Published 6 years ago • 530 plays • Length 3:16Download video MP4
Download video MP3
Similar videos
-
4:05
value focused midd: respiratory syncytial virus (rsv) model-informed drug development program
-
3:13
value focused midd: oncology model-informed drug development program
-
43:49
how can model informed drug development impact your program?
-
51:00
midd training module 4 – foundation to model informed drug development and model interconnectedness
-
1:12:39
strategic implementation of model-informed drug development (midd) for regulatory success
-
15:51
model informed drug development approaches for immunogenicity assessments workshop
-
33:21
using model based meta analysis to inform drug development for auto immune diseases
-
57:06
small molecules, biologics, and vaccines: three uniquely divergent roads to fda cmc approval
-
17:58
how ai is used in pharma and healthcare for clinical drug development - james cai, roche
-
1:07:46
development and delivery of pharmaceutical products (cmc) - mars best practices
-
45:33
using model-based meta-analysis to improve decision-making in drug development
-
22:52
regulatory perspectives for reliable model informed drug development (midd)
-
1:00:21
optimize drug development with public data and predictive models – model-based meta-analysis (mbma)
-
3:58
in vitro drug metabolism dataset
-
30:56
a drug development software and services overview with a focus on rsnlme and simcyp
-
35:08
fda modernization act - what does it mean for pharmaceutical scientists?
-
15:24
07_regulatory overview of the new drug development
-
55:53
mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology
-
20:21
model informed drug development approaches for immunogenicity assessments workshop
-
0:50
medicines for europe - value added medicines
-
10:37
midd training module 4 – case study 1: decision analysis to support drug development